BL
Insider
Biotechnology Value Fund Ii Lp
DirectorBiotechnology Value Fund Ii Lp (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $173.7M of KYMR (1,630,658 sh across 4 lots, as filed), executed Jun 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$173.7M
shares × price, as filed
Last traded
Jun 26
Filed Jun 26
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $173.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$173.7M1,630,658 sh across 4 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET